Skin autofluorescence and complications of diabetes: Does ethnic background or skin color matter?

Diabetes Technology and Therapeutics

Volumn 17, Issue 2, 2015, Pages 88-95

  Ahdi, Mohamed ^a   Gerdes, Victor E A ^a,b   Graaff, Reindert ^c   Kuipers, Saskia ^b   Smit, Andries J ^c   Meesters, Eelco W ^a  

^a Lotervaart Hospital   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; CUTANEOUS PARAMETERS; DIABETIC ANGIOPATHY; DIABETIC MACROANGIOPATHY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DUTCHMAN; ETHNIC DIFFERENCE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MOROCCAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SKIN AUTOFLUORESCENCE; SKIN COLOR; TURK (PEOPLE); ALGORITHM; BLOOD; COMPLICATION; EPIDEMIOLOGY; ETHNOLOGY; FLUORESCENCE; FLUORESCENCE IMAGING; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; SKIN; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BIOMARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; OPTICAL IMAGING; PREDICTIVE VALUE OF TESTS; SKIN;

EID: 84922463706     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0374     Document Type: Article

References (19)

1. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ: Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004;47:1324-1330.
2. Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ: Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005;16:3687-3693.
3. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, Smit AJ: Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 2006;29:2654-2659.
4. Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, Smit AJ, Gans RO, Bilo HJ: Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care 2008;31:517-521.
5. Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO, Bilo HJ, Smit AJ: Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia 2009;52:789-797.
6. Monami M, Lamanna C, Gori F, Bartalucci F, Marchionni N, Mannucci E: Skin autofluorescence in type 2 diabetes: beyond blood glucose. Diabetes Res Clin Pract 2008;79:56-60.
7. Tanaka K, Katoh T, Asai J, Nemoto F, Suzuki H, Asahi K, Sato K, Sakaue M, Miyata T, Watanabe T: Relationship of skin autofluorescence to cardiovascular disease in Japanese hemodialysis patients. Ther Apher Dial 2010;14:334-340.
8. Yue X, Hu H, Koetsier M, Graaff R, Han C: Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue. Diabet Med 2011;28:818-823.
9. Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988;124:869-871.
10. Mulder DJ, Water TV, Lutgers HL, Graaff R, Gans RO, Zijlstra F, Smit AJ: Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther 2006;8:523-535.
11. Koetsier M, Nur E, Chunmao H, Lutgers HL, Links TP, Smit AJ, Rakhorst G, Graaff R: Skin color independent assessment of aging using skin autofluorescence. Opt Express 2010;18:14416-14429.
12. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
13. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van LF, Greene T, Coresh J: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
14. Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO, Smit AJ: Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007;30:107-112.
15. Koetsier M, Lutgers H, Smit AJ, Links TP, Vries RD, Gans RO, Rakhorst G, Graaff R: Skin autofluorescence for the risk assessment of chronic complications in diabetes: a broad excitation range is sufficient. Opt Express 2009;17:509-519.
16. Pageon H, Zucchi H, Rousset F, Monnier VM, Asselineau D: Skin aging by glycation: lessons from the reconstructed skin model. Clin Chem Lab Med 2013;52:169-174.
17. Pageon H: Reaction of glycation and human skin: the effects on the skin and its components, reconstructed skin as a model. Pathol Biol (Paris) 2010;58:226-231.
18. Yoshinaga E, Kawada A, Ono K, Fujimoto E, Wachi H, Harumiya S, Nagai R, Tajima S: Ne-(Carboxymethyl)lysine modification of elastin alters its biological properties: implications for the accumulation of abnormal elastic fibers in actinic elastosis. J Invest Dermatol 2012;132:315-323.
19. Koetsier M, Lutgers HL, de Jonge C, Links TP, Smit AJ, Graaff R: Reference values of skin autofluorescence. Diabetes Technol Ther 2010;12:399-403.